cyclopentane has been researched along with Angor Pectoris in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, AK; Ahuja, RC; Chandra, M; Gupta, NN; Hasan, M | 1 |
| Christensen, CC; Kjekshus, J; Westheim, AS | 1 |
| Prahl, M; Prahl, P | 1 |
2 trial(s) available for cyclopentane and Angor Pectoris
| Article | Year |
|---|---|
A double-blind trial of penbutolol: a new beta-receptor blocking agent in the treatment of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Cyclopentanes; Depression, Chemical; Double-Blind Method; Heart Function Tests; Heart Rate; Humans; Physical Exertion; Propanolamines | 1976 |
[Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Blood Pressure; Butylamines; Clinical Trials as Topic; Cyclopentanes; Depression, Chemical; Exercise Test; Female; Heart Rate; Humans; Middle Aged; Placebos; Propanolamines; Pulmonary Ventilation; Stimulation, Chemical | 1973 |
1 other study(ies) available for cyclopentane and Angor Pectoris
| Article | Year |
|---|---|
Effect of penbutolol (Hoe 893 d) and practolol on exercise-induced angina pectoris 2 and 24 hours after a signle oral dose.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Blood Pressure; Cyclopentanes; Exercise Test; Heart Rate; Humans; Male; Middle Aged; Placebos; Practolol; Propanolamines | 1978 |